![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe PROMO |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
AUTOIMMUNE BULLOUS DISEASES
Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3):259-67
Copyright © 2012 EDIZIONI MINERVA MEDICA
language: English
Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases
Daniel B. S. 1, 2, Murrell D. F. 1, 2 ✉
1 Department of Dermatology, St George Hospital, Sydney, NSW, Australia; 2 University of New South Wales, Sydney, NSW, Australia
Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.